SATRALIZUMAB vs SAXAGLIPTIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SATRALIZUMAB vs SAXAGLIPTIN: Safety Overview
| Metric | SATRALIZUMAB | SAXAGLIPTIN |
|---|---|---|
| Total FAERS Reports | 219 | 2,468 |
| Deaths Reported | 16 | 263 |
| Death Rate | 7.3% | 10.7% |
| Hospitalizations | 108 | 838 |
| Average Patient Age | 51.6 yrs | 65.5 yrs |
| % Female Patients | 82.1% | 47.8% |
| FDA Approval Date | N/A | Jul 31, 2009 |
| Manufacturer | Genentech, Inc. | Glenmark Pharmaceuticals Inc., USA |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Discontinued |